photo Корреспондент.net
Scientists from Sweden and Finland have developed and successfully tested a vaccine against a group of viruses that, according to scientists, affect the development of type 1 diabetes. About this writes the University of Jyvaskyla portal. New vaccine protects against six known coxsackie virus strains belonging to the enterovirus family. Usually, Coxsackie virus is manifested by a rash, fever, diarrhea. In some cases, it can cause meningitis and myocarditis.. “According to many scientific observations, the Coxsackie virus can play a role in the development of type 1 diabetes, which is characterized by an autoimmune attack on insulin-producing beta cells of the pancreas,” the article says.. Scientists have conducted a series of experiments on rodents and they showed that the vaccine protects mice infected with Coxsackie from developing diabetes of the first degree. A team of scientists is currently planning a study with volunteers.. If the vaccine shows safety in humans, then in the future it is planned to use it in children with a genetic predisposition to developing type 1 diabetes. Previously, scientists said that smoking increases the risk of type 2 diabetes.. News from Telegram. Subscribe to our channel https: // t. me / korrespondentnet Author: 1.